Christopher G. Hayes - Net Worth and Insider Trading
Christopher G. Hayes Net Worth
The estimated net worth of Christopher G. Hayes is at least $131,159 dollars as of 2024-11-29. Christopher G. Hayes is the CHIEF LEGAL OFFICER of Verrica Pharmaceuticals Inc and owns about 105,773 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $131,159. Details can be seen in Christopher G. Hayes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher G. Hayes has not made any transactions after 2024-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher G. Hayes
Christopher G. Hayes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher G. Hayes owns 1 companies in total, including Verrica Pharmaceuticals Inc (VRCA) .
Click here to see the complete history of Christopher G. Hayes’s form 4 insider trades.
Insider Ownership Summary of Christopher G. Hayes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2024-08-27 | General Counsel |
Christopher G. Hayes Latest Holdings Summary
Christopher G. Hayes currently owns a total of 1 stock. Christopher G. Hayes owns 105,773 shares of Verrica Pharmaceuticals Inc (VRCA) as of August 27, 2024, with a value of $131,159.
Latest Holdings of Christopher G. Hayes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2024-08-27 | 105,773 | 1.24 | 131,159 |
Holding Weightings of Christopher G. Hayes
Christopher G. Hayes Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher G. Hayes has made a total of 6 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 2 buys and 4 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the sale of 35,713 shares on August 27, 2024, which brought Christopher G. Hayes around $93,211.
Insider Trading History of Christopher G. Hayes
- 1
Christopher G. Hayes Trading Performance
GuruFocus tracks the stock performance after each of Christopher G. Hayes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher G. Hayes is 11.92%. GuruFocus also compares Christopher G. Hayes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher G. Hayes within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher G. Hayes's insider trading performs compared to the benchmark.
Performance of Christopher G. Hayes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.85 | | | | | |
| Relative Return to S&P 500(%) | 14.83 | | | | | |
Christopher G. Hayes Ownership Network
Christopher G. Hayes Owned Company Details
What does Verrica Pharmaceuticals Inc do?
Who are the key executives at Verrica Pharmaceuticals Inc?
Christopher G. Hayes is the General Counsel of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include director & President and CEO Ted White , Chief Commercial Officer Joe Bonaccorso , and Chief Financial Officer Terry Kohler .
Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary
Over the past 18 months, Christopher G. Hayes made 4 insider transaction in Verrica Pharmaceuticals Inc (VRCA) with a net sale of 124,941. Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net sale of 150,999 shares made by Ted White , a net sale of 130,386 shares made by Joe Bonaccorso , and a net sale of 69,548 shares made by Gary Goldenberg .
In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 533,677 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,726,522 shares.
Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verrica Pharmaceuticals Inc Insider Transactions
Christopher G. Hayes Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher G. Hayes. You might contact Christopher G. Hayes via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
